newsGlobal pharmacovigilance market to value almost $15bn by 202828 April 2021 | By Hannah Balfour (European Pharmaceutical Review)Research suggests outsourcing and the increasing incidence of adverse drug reactions (ADR) will be primary drivers of growth in the global pharmacovigilance market.
newsIndustry standards group Align Biopharma expands to 23 members14 July 2017 | By Niamh Marriott (European Pharmaceutical Review)Align Biopharma, an industry technology standards group, introduced 14 leading biopharma companies and technology and service providers as new members.
